Founded in 2002, Cells4Life is one of the leading stem cell storage provider in the UK, with many years of experience and a proven track record. We are a dedicated, science-led organisation that offers the most advanced technologies for processing and storing your baby's umbilical cord blood. Cells4Life has more than 150,000 cord blood samples in our accredited storage laboratories in the UK and we have released samples for stem cell treatment of conditions such as brain injury, leukaemia, cerebral palsy, perinatal stroke, and autism.
Becoming a parent for the first time is an extraordinary experience! You will be filled with joy, excitement, and hope as your baby develops and the birth date draws nearer. However, you may also have a lot of questions about how to prepare for the birth of your child. One of these questions could be: "Should you save your newborn baby's cord blood with a private cord blood bank?"
You might have heard about cord blood banking from your doctor, friends, relatives or from online sources. Saving the umbilical cord blood at birth is a growing trend among expecting parents and some celebrities have done it as well. In fact, more than 5 million families have stored their baby's cord blood sample to protect their baby's health in the future.
Being able to save your newborn baby's cord blood is a unique opportunity for expecting parents as it can only be done right after your baby is born - when the umbilical cord is clamped and cut. Collecting the cord blood is performed by the doctor or midwife using a collection kit provided by your chosen cord blood bank. Once cord blood has been collected, it is then sent to the laboratory for testing, processing, and storage for many years.
Signing up to cord blood banking starts with researching for a cord blood bank that you think will be able to provide you with the best options. Speaking with a cord blood banking specialist is an efficient way to learn more about saving the cord blood if you find the information online to be overwhelming and time-consuming.
In this post, we are going to highlight 8 of the most important questions to ask the cord blood banking specialist to help you make the most out of your scheduled appointment - whether via phone call, online meeting, or physical meeting.
Umbilical cord blood is the blood found in a newborn baby’s umbilical cord. Expecting parents have the once-in-a-lifetime opportunity to collect and preserve the umbilical cord blood for many years. This collection and preservation practice is called cord blood banking. After the birth of the baby, once the umbilical cord is clamped and cut – the remaining cord blood is collected using a specialised collection kit and sent to a private cord blood bank laboratory for testing, processing and storage in liquid nitrogen tanks for years, until needed for transplant.
Hematopoietic stem cell transplants have been used to saved the lives of many thousands of cancer patients over the past few decades. They have been an absolute game changer in terms of survival rates.
However, before receiving a stem cell transfusion, cancer patients need to be treated with high dose of chemotherapy and radiation. This treatment kills the mutated cells which are causing the patient’s cancer, in a process known as ‘conditioning’.
Premature babies have a very difficult start to life. Their bodies are not adequately prepared for life outside of the womb and they are vulnerable to a range of illnesses.
One of the most common illnesses suffered by premature babies is called necrotising enterocolitis. It is a life-threatening disease of the bowels, which affects about 10% of all pre-term babies.
Pulmonary Fibrosis is a potentially life-threatening condition caused by scarring of the lungs. It leads to a variety of dangerous complications including lung cancer, pulmonary hypertensions, pneumothorax, and respiratory failure.
A new study suggests that pulmonary fibrosis could be treated with umbilical cord stem cells. The study, titled “Extracellular vesicles derived from umbilical cord mesenchymal stromal cells alleviate pulmonary fibrosis by means of transforming growth factor-β signaling inhibition” was recently published in Stem Cell Research & Therapy.
The results of a Phase II clinical trial investigating the use of umbilical cord blood mesenchymal stem cells (MSCs) to treat bronchopulmonary dysplasia (BPD) have recently been published.
Bronchopulmonary dysplasia is a lung disease which affects newborn babies. It is particularly common in premature infants and babies with a low birth weight. Researchers believe that the condition is exacerbated by or caused by prolonged mechanical ventilation.